Understanding the concept of uncertainty in patients with indolent lymphoma

被引:21
|
作者
Elphee, Erin Elizabeth [1 ]
机构
[1] Canc Care Manitoba, Malignant Hematol & Lymphoma Dis Site Grp, Winnipeg, MB, Canada
关键词
D O I
10.1188/08.ONF.449-454
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose/Objectives: To review the literature on uncertainty in cancer populations, apply this concept to patients diagnosed with indolent lymphoma, identify sources of uncertainty, and present interventions aimed at assessing and addressing the management of uncertainty. Data Sources: English-language literature related to uncertainty in adult patients with cancer, psychological distress, and non-Hodgkin lymphoma, located through electronic databases PubMed (R) and CINAHL (R), hand searches, and personal contacts. Data Synthesis: Review of the literature revealed that uncertainty is being managed in breast cancer survivors and patients with prostate cancer with watchful waiting or active surveillance. The chronic and incurable nature of indolent lymphoma, coupled with symptoms that are vague and transient, are possible sources of uncertainty in patients diagnosed with lymphoma. Nursing interventions should be aimed at assessing, educating, and supporting patients as they work toward a new view of life that incorporates uncertainty. Conclusions: Literature about the experience of patients diagnosed with lymphoma is lacking. The concept of uncertainty should be recognized by clinicians as an important aspect of living with indolent lymphoma because it is present throughout the disease trajectory and, if left untreated, can have a negative effect on patients' overall quality of life. Implications for Nursing: Uncertainty should become an ongoing component of nursing assessment in patients diagnosed with lymphoma. Further research is needed to support the application of uncertainty theory to this patient population.
引用
收藏
页码:449 / 454
页数:6
相关论文
共 50 条
  • [21] Identification of patients with indolent B cell lymphoma sensitive to rituximab monotherapy
    Divi Cornec
    Adrian Tempescul
    Solène Querellou
    Pascal Hutin
    Jacques-Olivier Pers
    Christophe Jamin
    Boutahar Bendaoud
    Christian Berthou
    Yves Renaudineau
    Pierre Youinou
    Annals of Hematology, 2012, 91 : 715 - 721
  • [22] Comparisons of 131I-rituximab treatment responses in patients with aggressive lymphoma and indolent lymphoma
    Inki Lee
    Byung Hyun Byun
    Ilhan Lim
    Byung Il Kim
    Chang Woon Choi
    Kyeong Min Kim
    Dong-Yeop Shin
    Hye Jin Kang
    Sang Moo Lim
    Annals of Nuclear Medicine, 2019, 33 : 881 - 890
  • [23] Comparisons of 131I-rituximab treatment responses in patients with aggressive lymphoma and indolent lymphoma
    Lee, Inki
    Byun, Byung Hyun
    Lim, Ilhan
    Kim, Byung Il
    Choi, Chang Woon
    Kim, Kyeong Min
    Shin, Dong-Yeop
    Kang, Hye Jin
    Lim, Sang Moo
    ANNALS OF NUCLEAR MEDICINE, 2019, 33 (12) : 881 - 890
  • [24] Immunoglobulin-Substitution in Patients with indolent Non-Hodgkins- Lymphoma
    Weide, R.
    Feiten, S.
    Friesenhahn, V.
    Heymanns, J.
    Kleboth, K.
    Thomalla, J.
    van Roye, C.
    Koeppler, H.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (19) : E201 - E206
  • [25] Consolidative Radioimmunotherapy after Chemoimmunotherapy in Patients with Histologic Transformation of Indolent Lymphoma
    Reagan, Patrick M.
    Kelly, Jennifer L.
    Baran, Andrea
    Barr, Paul M.
    Casulo, Carla
    Chengazi, Vaseem
    Friedberg, Jonathan W.
    BLOOD, 2014, 124 (21)
  • [26] Effectiveness of radiotherapy for patients with indolent non-Hodgkin's lymphoma
    Hadi, I.
    Schummer, A.
    Eze, C.
    Dreyling, M.
    Belka, C.
    Li, M.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S487 - S488
  • [27] Age Differences in Quality of Life and Distress in Adult Patients with Indolent Lymphoma
    McConnell , Kelly
    PSYCHO-ONCOLOGY, 2023, 32 : 21 - 21
  • [28] Identification of patients with indolent B cell lymphoma sensitive to rituximab monotherapy
    Cornec, Divi
    Tempescul, Adrian
    Querellou, Solene
    Hutin, Pascal
    Pers, Jacques-Olivier
    Jamin, Christophe
    Bendaoud, Boutahar
    Berthou, Christian
    Renaudineau, Yves
    Youinou, Pierre
    ANNALS OF HEMATOLOGY, 2012, 91 (05) : 715 - 721
  • [29] The optimal sequence of treatment in indolent lymphoma: follicular lymphoma
    Viardot, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 168 - 168
  • [30] Retreatment with bendamustine in patients with relapsed/refractory indolent B-cell lymphoma and mantle cell lymphoma
    Yamada, Toshiki
    Shibata, Yuhei
    Nakamura, Nobuhiko
    Kitagawa, Jun-ichi
    Kasahara, Senji
    Goto, Hideko
    Fukuno, Kenji
    Hara, Takeshi
    Tsurumi, Hisashi
    ANNALS OF ONCOLOGY, 2016, 27